IX vs. TEVA
IX (ORIX Corporation) and TEVA (Teva Pharmaceutical Industries Limited) are both stocks. IX operates in Credit Services (Financial Services), while TEVA operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, IX returned 13.56%/yr vs -3.83%/yr for TEVA. At a 0.19 correlation, their price movements are largely independent.
Performance
IX vs. TEVA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IX achieves a 32.34% return, which is significantly higher than TEVA's 10.96% return. Over the past 10 years, IX has outperformed TEVA with an annualized return of 13.56%, while TEVA has yielded a comparatively lower -3.83% annualized return.
IX
- 1D
- -0.10%
- 1M
- 1.87%
- YTD
- 32.34%
- 6M
- 34.13%
- 1Y
- 80.82%
- 3Y*
- 33.19%
- 5Y*
- 19.80%
- 10Y*
- 13.56%
TEVA
- 1D
- 0.20%
- 1M
- -4.47%
- YTD
- 10.96%
- 6M
- 16.25%
- 1Y
- 95.54%
- 3Y*
- 66.30%
- 5Y*
- 25.53%
- 10Y*
- -3.83%
IX vs. TEVA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IX ORIX Corporation | 32.34% | 43.44% | 17.66% | 19.98% | -19.17% | 31.62% | -4.86% | 16.58% | -15.61% | 10.64% |
TEVA Teva Pharmaceutical Industries Limited | 10.96% | 41.61% | 111.11% | 14.47% | 13.86% | -16.99% | -1.53% | -36.45% | -18.63% | -46.18% |
Correlation
The correlation between IX and TEVA is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.33 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Sep 16, 1998 | 0.19 |
The correlation between IX and TEVA shifts across timeframes, from 0.19 (all time) to 0.33 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
IX:
$42.01B
TEVA:
$40.83B
IX:
¥401.75
TEVA:
$1.34
IX:
15.42
TEVA:
25.89
IX:
1.04
TEVA:
0.20
IX:
2.07
TEVA:
2.33
IX:
1.49
TEVA:
4.96
IX:
¥3.34T
TEVA:
$17.35B
IX:
¥1.17T
TEVA:
$9.03B
IX:
¥1.27T
TEVA:
$3.05B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IX vs. TEVA — Risk / Return Rank
IX
TEVA
IX vs. TEVA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ORIX Corporation (IX) and Teva Pharmaceutical Industries Limited (TEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IX | TEVA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.58 | ||
| Sortino ratioReturn per unit of downside risk | +0.20 | ||
| Omega ratioGain probability vs. loss probability | 1.51 | 1.47 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 4.00 | 4.41 | -0.41 |
| Martin ratioReturn relative to average drawdown | 11.49 | 12.66 | -1.17 |
Loading charts...
Drawdowns
IX vs. TEVA - Drawdown Comparison
The maximum IX drawdown since its inception was -93.82%, roughly equal to the maximum TEVA drawdown of -90.89%. Use the drawdown chart below to compare losses from any high point for IX and TEVA.
Loading charts...
Drawdown Indicators
| IX | TEVA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.82% | -90.89% | -2.93% |
Max Drawdown (1Y)Largest decline over 1 year | -20.33% | -21.79% | +1.46% |
Max Drawdown (3Y)Largest decline over 3 years | -24.34% | -43.70% | +19.36% |
Max Drawdown (5Y)Largest decline over 5 years | -37.67% | -43.70% | +6.03% |
Max Drawdown (10Y)Largest decline over 10 years | -47.23% | -88.41% | +41.18% |
Current DrawdownCurrent decline from peak | -3.13% | -48.81% | +45.68% |
Average DrawdownAverage peak-to-trough decline | -44.93% | -32.00% | -12.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.07% | 7.72% | -0.65% |
Volatility
IX vs. TEVA - Volatility Comparison
The current volatility for ORIX Corporation (IX) is 9.27%, while Teva Pharmaceutical Industries Limited (TEVA) has a volatility of 10.61%. This indicates that IX experiences smaller price fluctuations and is considered to be less risky than TEVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IX | TEVA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.27% | 10.61% | -1.34% |
Volatility (6M)Calculated over the trailing 6-month period | 22.55% | 23.72% | -1.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.73% | 39.04% | -12.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.07% | 42.82% | -17.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.70% | 47.35% | -21.65% |
Dividends
IX vs. TEVA - Dividend Comparison
IX's dividend yield for the trailing twelve months is around 1.55%, while TEVA has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IX ORIX Corporation | 1.55% | 3.43% | 3.63% | 3.22% | 1.94% | 0.00% | 2.17% | 0.00% | 0.00% | 1.41% | 2.40% | 0.00% |
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.88% | 3.19% | 1.77% |
Financials
IX vs. TEVA - Financials Comparison
This section allows you to compare key financial metrics between ORIX Corporation and Teva Pharmaceutical Industries Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
IX vs. TEVA - Profitability Comparison
IX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ORIX Corporation reported a gross profit of 326.61B and revenue of 938.86B. Therefore, the gross margin over that period was 34.8%.
TEVA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a gross profit of 1.97B and revenue of 3.98B. Therefore, the gross margin over that period was 49.5%.
IX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ORIX Corporation reported an operating income of 415.02B and revenue of 938.86B, resulting in an operating margin of 44.2%.
TEVA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported an operating income of 652.00M and revenue of 3.98B, resulting in an operating margin of 16.4%.
IX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ORIX Corporation reported a net income of 58.65B and revenue of 938.86B, resulting in a net margin of 6.3%.
TEVA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a net income of 369.00M and revenue of 3.98B, resulting in a net margin of 9.3%.
Frequently Asked Questions
IX and TEVA have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TEVA has higher volatility (10.61%) compared to IX (9.27%). In terms of maximum drawdown, IX dropped -93.82% vs TEVA's -90.89%.
IX currently has the higher Sharpe Ratio (3.04 vs 2.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IX and TEVA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer